UV-induced squamous cell carcinoma - A role for antiapoptotic signalling pathways

British Journal of Dermatology

Volumn 161, Issue SUPPL. 3, 2009, Pages 107-115

  Rodust, P M ^a   Stockfleth, E ^a   Ulrich, C ^a   Leverkus, M ^b   Eberle, J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Actinic keratosis; Apoptosis; Bcl 2 proteins; COX 2; Death ligands; EGF receptor; JNK; P38; SCC

Indexed keywords

CASPASE; CYCLOOXYGENASE 2; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DICLOFENAC; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIGEN; FAS LIGAND; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE C DELTA; PROTEIN MCL 1; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACTINIC KERATOSIS; APOPTOSIS; CANCER INHIBITION; CANCER MODEL; CANCER PATIENT; CANCER RISK; DISEASE ASSOCIATION; DNA DAMAGE; DOWN REGULATION; DRUG EFFECT; ENZYME REGULATION; GENE ACTIVATION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; KERATINOCYTE; MITOCHONDRION; MOLECULAR MECHANICS; MUTAGENICITY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIOSENSITIVITY; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; ULTRAVIOLET RADIATION; UPREGULATION;

APOPTOSIS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DNA DAMAGE; HUMANS; MITOCHONDRIA; NEOPLASMS, RADIATION-INDUCED; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; ULTRAVIOLET RAYS;

EID: 70349327819     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09458.x     Document Type: Review

References (106)

1. Trakatelli M, Ulrich C, del Marmol V et al. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007 156 : 1 7.
2. Hauschild A, Popp G, Stockfleth E et al. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch. Exp Dermatol 2009 18 : 116 121.
3. Clayman GL, Lee JJ, Holsinger FC et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005 23 : 759 765.
4. Buckman SY, Gresham A, Hale P et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998 19 : 723 729.
5. deLaat A, vanTilburg M, vanderLeun JC et al. Cell cycle kinetics following UVA irradiation in comparison to UVB and UVC irradiation. Photochem Photobiol 1996 63 : 492 497.
6. Nishigori C. Cellular aspects of photocarcinogenesis. Photochem Photobiol Sci 2006 5 : 208 214.
7. Nakabeppu Y, Sakumi K, Sakamoto K et al. Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids. Biol Chem 2006 387 : 373 379.
8. Wulff BC, Schick JS, Thomas-Ahner JM et al. Topical treatment with OGG1 enzyme affects UVB-induced skin carcinogenesis. Photochem Photobiol 2008 84 : 317 321.
9. Kunisada M, Sakumi K, Tominaga Y et al. 8-Oxoguanine formation induced by chronic UVB exposure makes Ogg1 knockout mice susceptible to skin carcinogenesis. Cancer Res 2005 65 : 6006 6010.
10. Aszterbaum M, Epstein J, Oro A et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 1999 5 : 1285 1291.
11. Yuspa SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J Dermatol Sci 1998 17 : 1 7.
12. Conney AH, Kramata P, Lou YR et al. Effect of caffeine on UVB-induced carcinogenesis, apoptosis, and the elimination of UVB-induced patches of p53 mutant epidermal cells in SKH-1 mice. Photochem Photobiol 2008 84 : 330 338.
13. Eberle J, Fecker LF, Forschner T et al. Apoptosis pathways as promising targets for skin cancer therapy. Br J Dermatol 2007 156 : 18 24.
14. Chang LF, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001 410 : 37 40.
15. Christmann M, Tomicic MT, Aasland D et al. A role for UV-light-induced c-Fos: stimulation of nucleotide excision repair and protection against sustained JNK activation and apoptosis. Carcinogenesis 2007 28 : 183 190.
16. Tournier C, Hess P, Yang DD et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000 288 : 870 874.
17. Hildesheim J, Awwad RT, Fornace AJ. p38 mitogen-activated protein kinase inhibitor protects the epidermis against the acute damaging effects of ultraviolet irradiation by blocking apoptosis and inflammatory responses. J Invest Dermatol 2004 122 : 497 502.
18. Lei K, Davis RJ. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 2003 100 : 2432 2437.
19. Wang X, Xing D, Liu L et al. BimL directly neutralizes Bcl-xL to promote Bax activation during UV-induced apoptosis. FEBS Lett 2009 583 : 1873 1879.
20. Shimada K, Nakamura M, Ishida E et al. Roles of p38-and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 2003 24 : 1067 1075.
21. Hofseth LJ, Hussain SP, Harris CC. p53: 25 years after its discovery. Trends Pharmacol Sci 2004 25 : 177 181.
22. Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003 10 : 26 35.
23. Leverkus M, Diessenbacher P, Geserick P. FLIP ing the coin? Death receptor-mediated signals during skin tumorigenesis. Exp Dermatol 2008 17 : 614 622.
24. Hill LL, Ouhtit A, Loughlin SM et al. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 1999 285 : 898 900.
25. Leverkus M, Yaar M, Gilchrest BA. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 1997 232 : 255 262.
26. Filipowicz E, Adegboyega P, Sanchez RL et al. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas. Cancer 2002 94 : 814 819.
27. Klemke CD, Brenner D, Weiss EM et al. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death. Cancer Res 2009 69 : 4175 4183.
28. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006 12 : 440 450.
29. Leverkus M, Neumann M, Mengling T et al. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 2000 60 : 553 559.
30. Bachmann F, Buechner SA, Wernli M et al. Ultraviolet light downregulates CD95 ligand and trail receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. J Invest Dermatol 2001 117 : 59 66.
31. Qin JZ, Bacon P, Panella J et al. Low-dose UV-radiation sensitizes keratinocytes to TRAIL-induced apoptosis. J Cell Physiol 2004 200 : 155 166.
32. Schwarz A, Mahnke K, Luger TA et al. Pentoxifylline reduces the formation of sunburn cells. Exp Dermatol 1997 6 : 1 5.
33. Leverkus M, Yaar M, Eller MS et al. Post-transcriptional regulation of UV induced TNF-alpha expression. J Invest Dermatol 1998 110 : 353 357.
34. Lind MH, Rozell B, Wallin RPA et al. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappa B inhibition. Proc Natl Acad Sci USA 2004 101 : 4972 4977.
35. Zhang JY, Adams AE, Ridky TW et al. Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia. Cancer Res 2007 67 : 3827 3834.
36. Grosse-Wilde A, Voloshanenko O, Bailey SL et al. TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. J Clin Invest 2008 118 : 100 110.
37. Schafer ZT, Kornbluth S. The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 2006 10 : 549 561.
38. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998 17 : 37 49.
39. Lei K, Nimnual A, Zong WX et al. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH2-terminal kinase. Mol Cell Biol 2002 22 : 4929 4942.
40. Cho SH, Delehedde M, Rodriguez-Villanueva J et al. Bax gene disruption alters the epidermal response to ultraviolet irradiation and in vivo induced skin carcinogenesis. Int J Mol Med 2001 7 : 235 241.
41. Nijhawan D, Fang M, Traer E et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003 17 : 1475 1486.
42. Sitailo LA, Tibudan SS, Denning MF. The protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis. J Biol Chem 2006 281 : 29703 29710.
43. D'Costa AM, Denning MF. A caspase-resistant mutant of PKC-delta protects keratinocytes from UV-induced apoptosis. Cell Death Differ 2005 12 : 224 232.
44. Zhang Y, Xing D, Liu L. PUMA promotes Bax translocation by both directly interacting with Bax and by competitive binding to Bcl-X L during UV-induced apoptosis. Mol Cell Biol 2009 20 : 3077 3087.
45. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007 7 : 295 308.
46. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005 26 : 1657 1667.
47. Cooper SJ, Bowden GT. Ultraviolet B regulation of transcription factor families: roles-of nuclear factor-kappa B (NF-kappa B) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. Curr Cancer Drug Targets 2007 7 : 325 334.
48. Kim DJ, Murray IA, Burns AM et al. Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem 2005 280 : 9519 9527.
49. Rodriguez-Puebla ML, Robles AI, Johnson DG et al. Synchronized proliferation induced by 12-O-tetradecanoylphorbol-13-acetate treatment of mouse skin: an in vivo model for cell cycle regulation. Cell Growth Differ 1998 9 : 31 9.
50. Ortonne JP. From actinic keratosis to squamous cell carcinoma. Br J Dermatol 2002 146 : 20 3.
51. Nindl I, Gottschling M, Krawtchenko N et al. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis. Br J Dermatol 2007 156 : 34 9.
52. Ziegler A, Jonason AS, Leffell DJ et al. Sunburn and p53 in the onset of skin-cancer. Nature 1994 372 : 773 776.
53. Berg RJW, vanKranen HJ, Rebel HG et al. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci USA 1996 93 : 274 278.
54. El-Deiry WS. Targeting mutant p53 shows promise for sunscreens and skin cancer. J Clin Invest 2007 117 : 3658 3660.
55. Stout GJ, Westdijk D, Calkhoven DM et al. Epidermal transit of replication-arrested, undifferentiated keratinocytes in UV-exposed XPC mice: an alternative to in situ apoptosis. Proc Natl Acad Sci U S A 2005 102 : 18980 18985.
56. Wikonkal NM, Brash DE. Ultraviolet radiation induced signature mutations in photocarcinogenesis. J Investig Dermatol Symp.Proc 1999 4 : 6 10.
57. Chao DL, Eck JT, Brash DE et al. Preneoplastic lesion growth driven by the death of adjacent normal stem cells. Proc Natl Acad Sci U S A 2008 105 : 15034 15039.
58. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 1996 274 : 1194 1197.
59. Peus D, Vasa RA, Meves A et al. H2O2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol 1998 110 : 966 971.
60. Xu YR, Shao Y, Voorhees JJ et al. Oxidative inhibition of receptor-type protein-tyrosine phosphatase kappa by ultraviolet irradiation activates epidermal growth factor receptor in human keratinocytes. J Biol Chem 2006 281 : 27389 27397.
61. Rundhaug JE, Fischer SM. Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem Photobiol 2008 84 : 322 329.
62. Xu YR, Voorhees JJ, Fisher GJ. Epidermal growth factor receptor is a critical mediator of ultraviolet B irradiation-induced signal transduction in immortalized human keratinocyte HaCaT cells. Am J Pathol 2006 169 : 823 830.
63. Bachelor MA, Cooper SJ, Sikorski ET et al. Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase decreases UVB-induced activator protein-1 and cyclooxygenase-2 in a SKH-1 hairless mouse model. Mol Cancer Res 2005 3 : 90 9.
64. Rygiel TP, Mertens AE, Strumane K et al. The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation. J Cell Sci 2008 121 : 1183 1192.
65. Dittmann K, Mayer C, Fehrenbacher B et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 2005 280 : 31182 31189.
66. Xu Y, Shao Y, Zhou J et al. Regulation of ultraviolet irradiation induced epidermal growth factor receptor nuclear translocation by receptor protein tyrosine phosphatase-kappa in human keratinocytes. J Invest Dermatol 2009 129 : S96.
67. El Abaseri TB, Fuhrman J, Trempus C et al. Chemoprevention of UV light-induced skin tumorigenesis by inhibition of the epidermal growth factor receptor. Cancer Res 2005 65 : 3958 3965.
68. Higashi Y, Kanekura T, Kanzaki T. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression. Int J Cancer 2000 86 : 667 671. (Pubitemid 30249877)
69. An KP, Athar M, Tang XW et al. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approach. Photochem Photobiol 2002 76 : 73 80.
70. Pentland AP, Schoggins JW, Scott GA et al. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999 20 : 1939 1944.
71. Butler GJ, Neale R, Green AC et al. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. J Am Acad Dermatol 2005 53 : 966 972.
72. Grau MV, Baron JA, Langholz B et al. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int J Cancer 2006 119 : 682 686.
73. Stockfleth E, Kerl H. Guidelines for the management of actinic keratoses - developed by the guideline subcommittee of the European dermatology forum. Eur J Dermatol 2006 16 : 599 606.
74. Fecker LF, Stockfleth E, Nindl I et al. The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs). Br J Dermatol 2007 156 : 25 33.
75. Fischer SM, Pavone A, Mikulec C et al. Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis. Mol Carcinog 2007 46 : 363 371.
76. Tripp CS, Blomme EAG, Chinn KS et al. Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection. J Invest Dermatol 2003 121 : 853 861.
77. Watabe A, Sugimoto Y, Honda A et al. Cloning and Expression of Cdna for A Mouse Ep(1) Subtype of Prostaglandin-e Receptor. J Biol Chem 1993 268 : 20175 20178.
78. Kiriyama M, Ushikubi F, Kobayashi T et al. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1997 122 : 217 224.
79. Fujino H, West KA, Regan JW. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E-2. J Biol Chem 2002 277 : 2614 2619.
80. Chun KS, Akunda JK, Langenbach R. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E-2 receptors, EP2 and EP4. Cancer Res 2007 67 : 2015 2021.
81. Tober KL, Wilgus TA, Kusewitt DF et al. Importance of the EP1 receptor in cutaneous UVB-induced inflammation and tumor development. J Invest Dermatol 2006 126 : 205 211.
82. Kern MA, Haugg AM, Koch AF et al. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res 2006 66 : 7059 7066.
83. Casado M, Molla B, Roy R et al. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes. Hepatology 2007 45 : 631 638.
84. Eberle J, Kurbanov BM, Hossini AM et al. Overcoming apoptosis deficiency of melanoma - Hope for new therapeutic approaches. Drug Resist Updat 2007 10 : 218 234.
85. Song G, Ouyang GL, Bao SD. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005 9 : 59 71.
86. Black AT, Gray JP, Shakarjian MR et al. UVB light upregulates prostaglandin synthases and prostaglandin receptors in mouse keratinocytes. Toxicol Appl Pharmacol 2008 232 : 14 24.
87. Isoherranen K, Punnonen K, Jansen C et al. Ultraviolet irradiation induces cyclooxygenase-2 expression in keratinocytes. Br J Dermatol 1999 140 : 1017 1022. (Pubitemid 29284571)
88. Subbaramaiah K, Altorki N, Chung WJ et al. Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 1999 274 : 10911 10915.
89. Bang B, Rygaard J, Baadsgaard O et al. Increased expression of Fas on human epidermal cells after in vivo exposure to single-dose ultraviolet (UV) B or long-wave UVA radiation. Br J Dermatol 2002 147 : 1199 1206.
90. Ouhtit A, Gorny A, Muller HK et al. Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis. Am J Pathol 2000 157 : 1975 1981.
91. Owen-Schaub LB, Zhang W, Cusack JC et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/Apo-1 expression. Mol Cell Biol 1995 15 : 3032 3040.
92. Wachter T, Sprick M, Hausmann D et al. cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes. J Biol Chem 2004 279 : 52824 52834.
93. Diessenbacher P, Hupe M, Sprick MR et al. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2. J Invest Dermatol 2008 128 : 1134 1147.
94. Grossman D, Mcniff JM, Li FZ et al. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 1999 79 : 1121 1126.
95. Lo Muzio L, Staibano S, Pannone G et al. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 2001 70 : 249 254.
96. Allen SM, Florell SR, Hanks AN et al. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Cancer Res 2003 63 : 567 572.
97. Cerroni L, Kerl H. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic cell-growth in cutaneous basal-cell carcinoma. J Cutan Pathol 1994 21 : 398 403.
98. Delehedde M, Cho SH, Sarkiss M et al. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Cancer 1999 85 : 1514 1522.
99. Puizina-Ivic N, Sapunar D, Marasovic D et al. An Overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis. Coll Antropol 2008 32 : 61 5.
100. Pena JC, Rudin CM, Thompson CB. A Bcl-x(L) transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res 1998 58 : 2111 2116.
101. Rossiter H, Beissert S, Mayer C et al. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis. Cancer Res 2001 61 : 3619 3626.
102. Jost M, Class R, Kari C et al. A central role of Bcl-X-L in the regulation of keratinocyte survival by autocrine EGFR ligands. J Invest Dermatol 1999 112 : 443 449.
103. Taylor JK, Zhang QQ, Monia BP et al. Inhibition of Bcl-x(L) expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Oncogene 1999 18 : 4495 4504.
104. Zhang J, Bowden GT. Targeting Bcl-X-L for prevention and therapy of skin cancer. Mol Carcinog 2007 46 : 665 670.
105. Kim DJ, Kataoka K, Sano S et al. Targeted disruption of Bcl-x(L) in mouse keratinocytes inhibits both UVB- and chemically induced skin carcinogenesis. Mol Carcinog 2009 PMID: 19309000, [Ahead of Print].
106. Wrone-Smith T, Bergstrom J, Quevedo ME et al. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions. J Dermatol Sci 1999 19 : 53 67.